1. See Detail

Website upgrades coming this February 2023! Read up on the FAQs to prepare for your account migration.

Bad Blood: Secrets and Lies in a Silicon Valley Startup (Paperback)

Quick Overview

New York Times Notable Book

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion.

Get Bad Blood: Secrets and Lies in a Silicon Valley Startup (Paperback) by John Carreyrou and other entrepreneurship books online and at Fully Booked bookstore branches in the Philippines.

Out of stock
₱715.00
D-coded

New York Times Notable Book
Washington Post Notable Book
 
One of the Best Books of the Year: NPR, San Francisco ChronicleTimeEsquireFortuneMarie ClaireGQMental FlossScience FridayBloombergPopular MechanicsBookRiotThe Seattle TimesThe OregonianPublishers WeeklyLibrary Journal

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion.

There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.

Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.

More Information
ISBN 9780525431992
Length (cm) 13.0000
Width (cm) 2.0000
Height (cm) 20.0000
Publisher Vintage
Publication Date Jan 28, 2020
Pages (number) 368
Genre Economics, Business & Leadership
Author John Carreyrou
Signed No
Format Paperback
Editorial Reviews

“Chilling. . . . Reads like a thriller. . . . Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review

Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account

No Related Posts

February Fully Booked Picks

Website Upgrades